Detalhe da pesquisa
1.
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.
Cell
; 185(9): 1539-1548.e5, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429436
2.
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.
Nature
; 607(7918): 351-355, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584773
3.
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections.
J Infect Dis
; 226(10): 1688-1698, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36134603
4.
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme.
J Clin Microbiol
; 60(7): e0026122, 2022 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766492
5.
Spatial transcriptomics identifies candidate stromal drivers of benign prostatic hyperplasia.
JCI Insight
; 9(2)2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971878
6.
Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C.
Cell Rep Med
; 4(6): 101034, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279751
7.
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Nat Microbiol
; 7(2): 277-288, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013591
8.
Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination.
medRxiv
; 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075459